Filing Details

Accession Number:
0001179110-11-012414
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-08-18 20:01:39
Reporting Period:
2011-08-17
Filing Date:
2011-08-18
Accepted Time:
2011-08-18 20:01:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1158223 Affymax Inc AFFY Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1419579 Anne-Marie Duliege C/O Affymax, Inc.
4001 Miranda Ave.
Palo Alto CA 94304
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-08-17 5,296 $4.73 24,704 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. In connection with the grant on September 22, 2010 of 30,000 shares of performance-based restricted stock units, 15,000 shares vested upon acceptance by the FDA of the NDA for peginesatide of which 5,296 shares were sold on August 17, 2011 pursuant to an order to satisfy tax withholding obligations that arose as a consequence of the vesting and delivery of the RSUs.